75N93019F00131 TA02 TO9 Development of a Protocol, Clinical Trial Implementation, Closeout and Analysis of a Phase 2 Clinical Trial to Evaluate the Eficacy of rMenB+OMV NZ (Bexsero, GSK) in Preventing Neisseria Gonorrhoese Infection

Grant

Date/time Interval

  • May 1, 2019 - September 5, 2021
  • Total Award Amount

  • 3532691.00
  • Direct Costs

  • 3120683.00
  • Sponsor Award Id

  • 75N93019F00131-HHSN272201300012I
  • Contributor

  • Jeanne Marrazzo   Principal Investigator  
  • Jodie Dionne-Odom   Investigator